Effect of bovine lactoferrin on seroconversion following polio vaccine administration in children: protocol for a double-blinded randomised controlled trial

Atif Habib, Sidrah Nausheen, Shanila Nooruddin, Tooba Javed, Tariq Samejo, Amjad Hussain, Suneeta Namdev, Sehrish Amirali, Muhammad Umer, Lumaan Sheikh, Imtiaz Hussain, Shabina Ariff, Sajid Soofi, Atif Habib, Sidrah Nausheen, Shanila Nooruddin, Tooba Javed, Tariq Samejo, Amjad Hussain, Suneeta Namdev, Sehrish Amirali, Muhammad Umer, Lumaan Sheikh, Imtiaz Hussain, Shabina Ariff, Sajid Soofi

Abstract

Introduction: The oral polio vaccine (OPV) has substantial results in eliminating wild poliovirus and the vaccine of choice in polio eradication. However, the mucosal immunity induced by the OPV is still uncertain. Literature has shown that bovine lactoferrin (BLF) is a safe and useful protein found in cow's milk with extraordinary antimicrobial, antiviral, antiinflammatory and immune-modulatory functions that help children's gut to fight against micro-organisms like poliovirus. However, limited data exist regarding the effect of BLF on polio vaccine immune response. The primary objective is to evaluate the effect of BLF in enhancing mucosal and humoral immunity in children following the administration of oral and inactivated polio vaccines.

Methods and analysis: This is a two-arm double-blinded randomised controlled trial comparing 462 neonates (231 in both groups) receiving either BLF or placebo with breast milk. The intervention is administered from day 1 till 6 weeks of age to a full-term healthy singleton newborn born at the Aga Khan University Hospitals, Karachi, Pakistan. The primary outcome is the seroconversion, 1 month after the receipt of two doses of OPV (at 10 weeks). For descriptive statistical analysis, Stata will be used, the frequency with percentages will be reported to describe baseline characteristics of the participants. A χ2 test will be used to compare categorical variables and a simple t test to compare continuous variables. The proportion of seroconversion and shedding will be compared using χ2 test or Fisher's exact test.

Ethics and dissemination: The Ethics approval has been granted by the Ethics Review Committee (ERC) of Aga Khan University for the proposed trial (ID: 2019-1955-5013). Furthermore, the National Bioethics Committee (NBC) of Pakistan has also approved the study for human subject research (ID: 4-87/NBC-443/19/669). Study findings will be disseminated through presentations at scientific conferences and educational practice workshops and will be published in an international peer-reviewed scientific journal.

Trial registration number: NCT04432935; ClinicalTrials.gov.

Keywords: NEONATOLOGY; PUBLIC HEALTH; Paediatric infectious disease & immunisation.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Cases of wild poliovirus by country and year. Available:
    1. Global polio eradication initiative, endemic countries. Available:
    1. Khan F, Datta SD, Quddus A, et al. . Progress Toward Polio Eradication - Worldwide, January 2016-March 2018. MMWR Morb Mortal Wkly Rep 2018;67:524–8. 10.15585/mmwr.mm6718a4
    1. Bandyopadhyay AS, Garon J, Seib K, et al. . Polio vaccination: past, present and future. Future Microbiol 2015;10:791–808. 10.2217/fmb.15.19
    1. World Health Organization, . Available:
    1. Agarwal A, Sharma D, Kumari S, et al. . Antibody response to three doses of standard and double dose of trivalent oral polio vaccine. Indian Pediatr 1991;28:1141–5.
    1. Sabin AB. Vaccination against poliomyelitis in economically underdeveloped countries. Bull World Health Organ 1980;58:141–57.
    1. John TJ, Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 1972;96:263–9. 10.1093/oxfordjournals.aje.a121457
    1. Sutter RW, Suleiman AJ, Malankar P, et al. . Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med 2000;343:767–73. 10.1056/NEJM200009143431103
    1. Triki H, Abdallah MV, Ben Aissa R, Ben AR, et al. . Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine 1997;15:1123–9. 10.1016/S0264-410X(97)00001-7
    1. Pan WK, Seidman JC, Ali A, et al. . Oral polio vaccine response in the MAL-ED birth cohort study: considerations for polio eradication strategies. Vaccine 2019;37:352–65. 10.1016/j.vaccine.2018.05.080
    1. Parker EP, Ramani S, Lopman BA, et al. . Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol 2018;13:97–118. 10.2217/fmb-2017-0128
    1. Haque R, Snider C, Liu Y, et al. . Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine 2014;32:478–82. 10.1016/j.vaccine.2013.11.056
    1. Saleem AF, Mach O, Quadri F, et al. . Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan. Vaccine 2015;33:2757–63. 10.1016/j.vaccine.2015.04.055
    1. Newell E, Sigal N, Haque R, et al. . Oral polio vaccination failure in urban slum children is associated with malnutrition and evidence of chronic inflammation (166.2).
    1. Government of Pakistan and UNICEF . National Nutrition Survey 2018 - Key Findings Report. Available:
    1. Rodríguez L, Cervantes E, Ortiz R. Malnutrition and gastrointestinal and respiratory infections in children: a public health problem. Int J Environ Res Public Health 2011;8:1174–205. 10.3390/ijerph8041174
    1. Prendergast AJ. Malnutrition and vaccination in developing countries. Philos Trans R Soc Lond B Biol Sci 2015;370:20140141. 10.1098/rstb.2014.0141
    1. Caidi H, Bennis F, Mouan N, et al. . [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco]. East Mediterr Health J 2004;10:474–81. 10.26719/2004.10.4-5.474
    1. Habib M, Soofi S, Ali N, et al. . A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Vaccine 2013;31:1987–93. 10.1016/j.vaccine.2013.02.003
    1. Hussain I, Mach O, Habib A, et al. . Seroprevalence of Anti-polio antibodies in children from polio high-risk areas of Pakistan: a cross-sectional survey 2015-2016. Pediatr Infect Dis J 2017;36:e230–6. 10.1097/INF.0000000000001622
    1. Jackson KM, Nazar AM. Breastfeeding, the immune response, and long-term health. J Am Osteopath Assoc 2006;106:203–7.
    1. Oddy WH. The impact of breastmilk on infant and child health. Breastfeed Rev 2002;10:5.
    1. Cacho NT, Lawrence RM. Innate immunity and breast milk. Front Immunol 2017;8:584. 10.3389/fimmu.2017.00584
    1. Jakaitis BM, Denning PW. Human breast milk and the gastrointestinal innate immune system. Clin Perinatol 2014;41:423–35. 10.1016/j.clp.2014.02.011
    1. World Health Organization . Breastfeeding gives babies the best possible start in life and breastmilk works like a baby’s first vaccine, 2020. Available:
    1. National Institute of Population Studies (NIPS) [Pakistan] and ICF . Pakistan demographic and health survey 2017-18. Islamabad, Pakistan, and Rockville, Maryland, USA: NIPS and ICF, 2018.
    1. Lönnerdal B. Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 2009;12:293–7. 10.1097/MCO.0b013e328328d13e
    1. Prentice A, Ewing G, Roberts SB, et al. . The nutritional role of breast-milk IgA and lactoferrin. Acta Paediatr Scand 1987;76:592–8. 10.1111/j.1651-2227.1987.tb10526.x
    1. Roseanu A, Brock JH. What are the structure and the biological function of lactoferrin in human breast milk? IUBMB Life 2006;58:235–7. 10.1080/15216540600577897
    1. Seganti L, Di Biase AM, Marchetti M, et al. . Antiviral activity of lactoferrin towards naked viruses. Biometals 2004;17:295–9. 10.1023/B:BIOM.0000027708.27142.bc
    1. Ochoa TJ, Cleary TG. Effect of lactoferrin on enteric pathogens. Biochimie 2009;91:30–4. 10.1016/j.biochi.2008.04.006
    1. Adlerova L, Bartoskova A, Faldyna M. Lactoferrin: a review. Veterinarni Medicina 2008;53:457–68. 10.17221/1978-VETMED
    1. Legrand D, Mazurier J. A critical review of the roles of host lactoferrin in immunity. Biometals 2010;23:365–76. 10.1007/s10534-010-9297-1
    1. Hwang S-A, Wilk KM, Budnicka M, et al. . Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis. Vaccine 2007;25:6730–43. 10.1016/j.vaccine.2007.07.005
    1. Hwang S-A, Arora R, Kruzel ML, et al. . Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c). Tuberculosis 2009;89 Suppl 1:S49–54. 10.1016/S1472-9792(09)70012-5
    1. World Health Organization . WHO guidelines on drawing blood: best practices in phlebotomy. Available:
    1. WHO Department of Immunization, Vaccines and Biologicals . Polio laboratory manual. Geneva: World Health Organization, 2004.
    1. Centers of Disease Control (CDC) . Diagnostic methods for polio. Available:

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner